Evaluating the Feasibility of Using Transdermal Patient-controlled Fentanyl After Spinal Fusions

Trial Profile

Evaluating the Feasibility of Using Transdermal Patient-controlled Fentanyl After Spinal Fusions

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 15 Feb 2018

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms IONSYS Pilot
  • Most Recent Events

    • 14 Feb 2018 Status changed from not yet recruiting to withdrawn prior to enrolment due to Contract not reached with sponsor.
    • 14 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
    • 14 Dec 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top